Inspection & Audit Management
Biostrategenix makes inspections predictable, not painful by helping you prepare with confidence, respond decisively, and close out issues fast. From audit prep and mock inspections to 483 and EU deficiency response strategy, we safeguard your regulatory standing, protect market access, and keep your business moving forward.
Our Services
Regulatory inspections can make or break a company’s reputation. Response to regulatory findings may also significantly impact corporate strategic timelines, and eventually bottom line. At Biostrategenix, we help pharmaceutical and biopharmaceutical firms prepare for audits with confidence, respond with precision, and close out issues quickly so you stay inspection-ready, avoid costly delays, and protect market access.
- Audit Preparation – End-to-end support for Pre-Approval, Surveillance, For-Cause, Follow-Up/Re-Inspection, Compliance, and Post-Approval inspections to ensure you meet regulatory expectations the first time.
- Mock Inspections & Readiness Training – Realistic simulations and targeted coaching that equip your teams to perform with confidence under pressure.
- 483 & Deficiency Response – Clear, defensible, and regulator-credible responses that minimize business disruption and restore confidence.
- Commitment Closure — where a finding becomes a regulatory commitment, closure is governed through the Remediation & Transformation PMO, not from here.
- Contamination Control Findings — sterile and aseptic observations route into Annex 1 & Microbiological Compliance, where the technical work is done.
We go beyond “check-the-box” readiness. Biostrategenix helps you turn regulatory agency inspections into opportunities to demonstrate control, resilience, and operational excellence while protecting revenue and patient trust.
How This Is Usually Scoped
Inspection preparation runs as a Focused Engagement. Where findings become regulatory commitments, closure runs as a Program Engagement governed through the Remediation & Transformation PMO. Either way it begins with a Rapid Diagnostic.
Related reading from Decoded
- The Hidden Challenges of ICH Q9 Quality Risk Management (And How to Solve Them)
- How Top Pharma Labs Cut Costs 40%: Lean Laboratory Implementation Guide